Another full-regimen HIV pill enters the market: Triumeq

August 22, 2014 - Project Inform.

Convenient options for treating HIV infection got a boost today as the new all-in-one pill called Triumeq was approved by the FDA. Triumeq is a full HIV regimen made up of the three drugs dolutegravir (Tivicay), abacavir (Ziagen) and lamivudine (Epivir). Dolutegravir is an integrase inhibitor while the other two drugs are NRTIs, also available as Epzicom. Four full-regimen pills are now available as HIV treatment: Triumeq, Stribild, Complera and Atripla.

This is the first all-in-one HIV pill approved by the FDA without Truvada (tenofovir/emtricitabine), which makes it a new choice for those with impaired kidney function. Continue reading…

 

like0

Do you get our newsletter?

admin's picture

Sign up for our monthly Newsletter and get the latest info in your inbox.

seventh name

Entrevistamos Arianna Lint, miembro del Consejo Asesor de la Comunidad y Una Chica Como Yo blogger, para nuestra "Enfoque: Mujeres Creando Diferencia" serie.

Learn about peripheral neuropathy – what it is, what puts people at risk of developing it, its signs and symptoms, and available treatments.

Obtener información acerca de las mujeres trans que viven con el VIH y los muchos problemas únicos que se enfrentan, incluyendo algunas buenas noticias sobre los cambios y la capacidad de recuperación determinado.

admin's picture

Join our community

Connect to our support community and share experiences with other women living with HIV.

Join now >

admin's picture

You Can Help!

Together, we can change the course of the HIV epidemic…one woman at a time!

Please donate now!>